Home › Funds › Smith Salley Wealth Management › ABBV

Smith Salley Wealth Management position in ABBV

ABBVIE INC · Health Care

Smith Salley Wealth Management reported holding 163,875 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$42.9M, representing 1.77% of its reported portfolio and ranking #13 among its reported holdings. Smith Salley Wealth Management has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)163.88K sh
Reported value held$42.87M
Portfolio Weight1.77%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Smith Salley Wealth Management's ABBV position evolved

Smith Salley Wealth Management first disclosed a stake in ABBV in Q3 2023 at 206,733 shares (US$30.8M). The position peaked in Q3 2026 at 163,875 shares, worth US$42.9M. Across 13 filings, Smith Salley Wealth Management increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 163,875 shares valued at US$42.9M — an increase of 4,801 shares quarter over quarter.. Notable position changes include a 25% trim in Q1 2024 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 206.73K $30.82M New
Q4 2023 210.55K $32.63M Add
Q1 2024 157.00K $28.59M Reduce
Q2 2024 165.25K $28.34M Add
Q3 2024 168.80K $33.33M Add
Q4 2024 170.18K $30.24M Add
Q1 2025 150.92K $31.62M Reduce
Q2 2025 154.01K $28.59M Add
Q3 2025 158.92K $36.80M Add
Q4 2025 157.38K $35.96M Reduce
Q1 2026 160.79K $34.97M Add
Q2 2026 159.07K $40.03M Reduce
Q3 2026 163.88K $42.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Smith Salley Wealth Management held ABBV?

Smith Salley Wealth Management has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Smith Salley Wealth Management's current position in ABBV?

As of Q3 2026, Smith Salley Wealth Management holds 163.88K shares of ABBV (ABBVIE INC), valued at $42.87M, representing 1.77% of its reported portfolio and ranking #13.

Has Smith Salley Wealth Management been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Smith Salley Wealth Management increased its position in ABBV. The position peaked in Q3 2026 at 163.88K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.